![](/images/graphics-bg.png)
Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails
المؤلفون المشاركون
Zhang, Zhenpeng
Wang, Jie
He, Qingyong
Chen, Yinfeng
Li, Bo
Li, Min
Feng, Bo
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2015، العدد 2015 (31 ديسمبر/كانون الأول 2015)، ص ص. 1-13، 13ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2015-07-13
دولة النشر
مصر
عدد الصفحات
13
التخصصات الرئيسية
الملخص EN
Objective.
To evaluate the efficacy and safety of Xuezhikang capsule treating type 2 diabetes with hyperlipidemia.
Methods.
We searched six databases to identify relevant studies published before January 2015.
Two review authors independently extracted data and assessed the Cochrane risk of bias tool.
We resolved disagreements with this assessment through discussion and a decision was achieved by consensus.
Results.
We included 21 studies (1548 participants).
Treatment courses were at least 8 weeks.
Overall, the risk of bias of included trials was unclear.
Among them, 16 studies could conduct meta-analysis.
The result showed that compared with routine group (5 studies), Xuezhikang group had more effect on decreasing TC, TG, LDL-C, and rising HDL-C.
However, compared with statins group (11 studies), Xuezhikang group has less effect on decreasing TC, TG, and rising HDL-C.
Meanwhile, two groups had no statistical differences of LDL-C level.
Conclusion.
Xuezhikang capsule may be effective for treating type 2 diabetes with hyperlipemia.
Our findings should be considered cautiously due to unclear risk of bias of the included studies and low methodological quality.
Therefore, more strictly designed large-scale randomized clinical trials are needed to evaluate the efficacy of Xuezhikang capsule in type 2 diabetes with hyperlipemia.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Li, Min& He, Qingyong& Chen, Yinfeng& Li, Bo& Feng, Bo& Zhang, Zhenpeng…[et al.]. 2015. Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails. Evidence-Based Complementary and Alternative Medicine،Vol. 2015, no. 2015, pp.1-13.
https://search.emarefa.net/detail/BIM-1061534
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Li, Min…[et al.]. Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails. Evidence-Based Complementary and Alternative Medicine No. 2015 (2015), pp.1-13.
https://search.emarefa.net/detail/BIM-1061534
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Li, Min& He, Qingyong& Chen, Yinfeng& Li, Bo& Feng, Bo& Zhang, Zhenpeng…[et al.]. Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails. Evidence-Based Complementary and Alternative Medicine. 2015. Vol. 2015, no. 2015, pp.1-13.
https://search.emarefa.net/detail/BIM-1061534
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1061534
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)